Leeds, UK, March 1, 2021 , – 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived
4d Pharma PLC (DDDD.L) Directorate Change
4D pharma makes strategic appointment of independent Non-Executive Director in response to new clinical success and next stages of global development